| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
 |
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | ||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Definitive Healthcare Corp. [ DH ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 11/22/2021 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
|||||||||||||||||||||||||
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Class A Common Stock | 11/22/2021 | D | 2,102,873(1) | D | $34.74 | 62,493,676(2) | I | See Notes(2)(3)(4) | ||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
| Explanation of Responses: |
| 1. See Exhibit 99.1 for text of footnote (1). |
| 2. See Exhibit 99.1 for text of footnote (2). |
| 3. See Exhibit 99.1 for text of footnote (3). |
| 4. See Exhibit 99.1 for text of footnote (4). |
| Remarks: |
| Christopher Egan, a Managing Partner of Advent and Lauren Young, a Managing Director of Advent (together, the "Advent Directors"), each serve on the board of directors of the Issuer, and have been deputized to represent the Reporting Persons on the board of directors. By virtue of the Advent Directors' representation, for purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons may be deemed directors by deputization of the Issuer. The Advent Directors have filed separate Section 16 reports disclosing securities of the Issuer that they may be deemed to beneficially own for Section 16 purposes. Exhibit 99.1 (Footnotes to Form 4) and Exhibit 99.2 (Signatures and Joint Filer Information) are incorporated by reference. Form 2 of 5: This Form 4 is the second of five Forms 4 being filed relating to the same event. The Form 4 has been split into multiple filings because there are more than 10 Reporting Persons total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. Each Form 4 will be filed by Designated Filer Advent International Corporation. |
| ADVENT INTERNATIONAL CORPORATION, By: /s/ Neil Crawford, Name: Neil Crawford, Title: Director, Fund Administration | 11/24/2021 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
Exhibit 99.1
Footnotes to Form 4
|
(1)
|
Represents shares of Class A common stock sold to the Issuer by the following entities: (i) 570,543 shares sold by Advent International GPE IX Limited Partnership (“GPE-IX LP”), (ii) 113,055 shares sold by Advent International GPE IX-B
Limited Partnership (“GPE IX-B LP”), (iii) 46,933 shares sold by Advent International GPE IX-C Limited Partnership (“GPE IX-C LP”), (iv) 49,242 shares sold by Advent International GPE IX-F Limited Partnership (“GPE IX-F LP”), (v) 162,029
shares sold by Advent International GPE IX-G Limited Partnership (“GPE IX-G LP”), (vi) 182,680 shares sold by Advent International GPE IX-H Limited Partnership (“GPE IX-H LP”), (vii) 103,474 shares sold by Advent International GPE IX-I
Limited Partnership (“GPE IX-I LP”), (viii) 167,771 shares sold by Advent International GPE IX-A SCSP (“GPE IX-A SCSP”), (ix) 35,710 shares sold by Advent International GPE IX-D SCSP (“GPE IX-D SCSP”), (x) 72,572 shares sold by Advent
International GPE IX-E SCSP (“GPE IX-E SCSP”), (xi) 3,278 shares sold Advent International GPE IX Strategic Investors SCSP (“GPE IX Strategic Investors SCSP”), (xii) 1,872 shares sold by Advent Partners GPE IX Limited Partnership (“AP GPE
IX LP”), (xiii) 4,330 shares sold by Advent Partners GPE IX-A Limited Partnership (“AP GPE IX-A LP”), (xiv) 10,804 shares sold by Advent Partners GPE IX Cayman Limited Partnership (“AP GPE IX Cayman LP”), (xv) 1,821 shares sold by Advent
Partners GPE IX-A Cayman Limited Partnership (“AP GPE IX-A Cayman LP”), (xvi) 30,234 shares sold by Advent Partners GPE IX-B Cayman Limited Partnership (“AP GPE IX-B Cayman LP”), (xvii) 128,499 shares sold by Advent Global Technology
Limited Partnership (“Global Technology LP”), (xviii) 100,002 shares sold by Advent Global Technology-B Limited Partnership (“Global Technology-B LP”), (xix) 54,144 shares sold by Advent Global Technology-C Limited Partnership (“Global
Technology-C LP”), (xx) 64,822 shares sold by Advent Global Technology-D Limited Partnership (“Global Technology-D LP”), (xxi) 63,431 by Advent Global Technology-A SCSP (“Global Technology-A SCSP”), (xxii) 202 shares sold by Advent Partners
AGT Limited Partnership (“AGT LP”), (xxiii) 921 shares sold by Advent Partners AGT-A Limited Partnership (“AGT-A LP”), (xxiv) 11,538 shares sold by Advent Partners AGT Cayman Limited Partnership (“AGT Cayman LP”), (xxv) 1,028 shares sold by
Advent Global Technology Strategic Investors Limited Partnership (“AGT Strategic Investors LP”) and (xxvi) 121,938 shares sold by Sunley House Master Fund Limited Partnership (“Sunley House Master Fund”). This transaction was approved by
the board of directors of the Issuer for purposes of Rule 16b-3 of the Securities Exchange Act of 1934, as amended.
|
|
(2)
|
Following the reported transactions, Advent International Corporation (“Advent”) manages funds that collectively own 62,493,676 shares of Class A common stock of the Issuer, which are represented as follows: (i) 16,955,510 shares are
held directly by GPE-IX LP, (ii) 3,359,809 shares are held directly GPE IX-B LP, (iii) 1,394,766 shares are held directly by GPE IX-C LP, (iv) 1,463,380 shares are held directly by GPE IX-F LP, (v) 4,815,226 shares are held directly by GPE
IX-G LP, (vi) 5,428,915 shares are held directly by GPE IX-H LP, (vii) 3,075,053 shares are held directly by GPE IX-I LP, (viii) 4,985,850 shares are held directly by GPE IX-A SCSP, (ix) 1,061,241 shares are held directly by GPE IX-D SCSP,
(x) 2,156,723 shares are held directly by GPE IX-E SCSP, (xi) 97,427 shares are held directly by GPE IX Strategic Investors SCSP, (xii) 55,642 shares are held directly by AP GPE IX LP, (xiii) 128,669 shares are held directly by AP GPE IX-A
LP, (xiv) 321,070 shares are held directly by AP GPE IX Cayman LP, (xv) 54,121 shares are held directly by AP GPE IX-A Cayman LP, (xvi) 898,507 shares are held directly by AP GPE IX-B Cayman LP, (xvii) 3,818,770 shares are held directly by
Global Technology LP, (xviii) 2,971,879 shares are held directly by Global Technology-B LP, (xix) 1,609,070 shares are held directly by Global Technology-C LP, (xx) 1,926,387 shares are held directly by Global Technology-D LP, (xxi)
1,885,069 shares are held directly by Global Technology-A SCSP, (xxii) 5,990 shares are held directly by AGT LP, (xxiii) 27,373 shares are held directly by AGT-A LP, (xxiv) 342,900 shares are held directly by AGT Cayman LP, (xxv) 30,542
shares are held directly by AGT Strategic Investors LP and (xxvi) 3,623,787 shares are held directly by Sunley House Master Fund.
|
|
(3)
|
GPE IX GP Limited Partnership is the general partner of GPE-IX LP, GPE IX-B LP, GPE IX-C LP, GPE IX-F LP, GPE IX-G LP, GPE IX-H LP and GPE IX-I LP. GPE IX GP S.à r.l. is the general partner of GPE IX-A
SCSP, GPE IX-D SCSP, GPE IX-E SCSP and GPE IX Strategic Investors SCSP. AP GPE IX GP Limited Partnership is the general partner of AP GPE IX LP, AP GPE IX-A LP, AP GPE IX Cayman LP, AP GPE IX-A Cayman LP and AP GPE IX-B Cayman LP. Advent
Global Technology GP Limited Partnership is the general partner of Global Technology LP, Global Technology-B LP, Global Technology-C LP and Global Technology-D LP. Advent Global Technology GP S.à r.l. is the general partner of
Technology-A SCSP. AP AGT GP Limited Partnership is the general partner of AGT LP, AGT-A LP, AGT Cayman LP and AGT Strategic Investors LP. Advent International GPE IX, LLC is the general partner of GPE IX GP Limited Partnership, AP GPE IX
GP Limited Partnership and GPE IX GP S.à r.l. Advent Global Technology LLC is the general partner of Advent Global Technology GP Limited Partnership, Advent Global Technology GP S.à r.l. and AP AGT GP Limited Partnership. Sunley House
Capital GP LP (“Sunley House GP LP”), as general partner of Sunley House Master Fund, Sunley House Capital GP LLC (“Sunley House GP LLC”), as general partner of Sunley House GP LP, and Sunley House Capital Management LLC (“Sunley House
Manager”), as investment manager to Sunley House Master Fund, may be deemed to beneficially own the shares held directly by Sunley House Master Fund. Advent is the manager of Advent International GPE IX, LLC and Advent Global Technology
LLC and is the sole member of both Sunley House GP LLC and Sunley House Manager. Investors in the Sunley House Master Fund invest in one or more of the following feeder funds: Sunley House Capital Fund LP, Sunley House Capital Limited
Partnership, Sunley House Capital Fund Ltd. and Sunley House Capital Ltd. (collectively, the “Sunley House Feeder Funds”), which are the limited partners of the Sunley House Master Fund. The Sunley House Feeder Funds have ownership
interests in the Sunley House Master Fund, but none of the Sunley House Feeder Funds owns shares directly and none has voting or dispositive power over the shares held directly by the Sunley House Master Fund.
|
|
(4)
|
Each Reporting Person disclaims Section 16 beneficial ownership of the shares reported herein except to the extent of
its pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of any of the reported shares for purposes of Section 16 or any other purpose.
|
Exhibit 99.2
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE IX LIMITED PARTNERSHIP
By: GPE IX GP Limited Partnership, its General Partner
By: Advent International GPE IX, LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-B Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE IX-B LIMITED PARTNERSHIP
By: GPE IX GP Limited Partnership, its General Partner
By: Advent International GPE IX, LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-C Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE IX-C LIMITED PARTNERSHIP
By: GPE IX GP Limited Partnership, its General Partner
By: Advent International GPE IX, LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-F Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE IX-F LIMITED PARTNERSHIP
By: GPE IX GP Limited Partnership, its General Partner
By: Advent International GPE IX, LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-G Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE IX-G LIMITED PARTNERSHIP
By: GPE IX GP Limited Partnership, its General Partner
By: Advent International GPE IX, LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-H Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE IX-H LIMITED PARTNERSHIP
By: GPE IX GP Limited Partnership, its General Partner
By: Advent International GPE IX, LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-I Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE IX-I LIMITED PARTNERSHIP
By: GPE IX GP Limited Partnership, its General Partner
By: Advent International GPE IX, LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-A SCSP
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX-A SCSP
|
|
|
By: GPE IX GP S.à r.l., its General Partner
|
|
|
By: Advent International GPE IX, LLC, its General Partner
|
/s/ Justin Nuccio
|
|
By: Advent International Corporation, its Manager
|
Justin Nuccio, Manager
|
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-D SCSP
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX-D SCSP
|
|
|
By: GPE IX GP S.à r.l., its General Partner
|
|
|
By: Advent International GPE IX, LLC, its General Partner
|
/s/ Justin Nuccio
|
|
By: Advent International Corporation, its Manager
|
Justin Nuccio, Manager
|
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-E SCSP
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX-E SCSP
|
|
|
By: GPE IX GP S.à r.l., its General Partner
|
|
|
By: Advent International GPE IX, LLC, its General Partner
|
/s/ Justin Nuccio
|
|
By: Advent International Corporation, its Manager
|
Justin Nuccio, Manager
|
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX Strategic Investors SCSP
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX
STRATEGIC INVESTORS SCSP
|
|
|
By: GPE IX GP S.à r.l., its General Partner
|
|
|
By: Advent International GPE IX, LLC, its General Partner
|
/s/ Justin Nuccio
|
|
By: Advent International Corporation, its Manager
|
Justin Nuccio, Manager
|
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE IX Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE IX LIMITED PARTNERSHIP
By: AP GPE IX Limited Partnership, its General Partner
By: Advent International GPE IX, LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE IX-A Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE IX-A LIMITED PARTNERSHIP
By: AP GPE IX Limited Partnership, its General Partner
By: Advent International GPE IX, LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE IX Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE IX CAYMAN LIMITED PARTNERSHIP
By: AP GPE IX Limited Partnership, its General Partner
By: Advent International GPE IX, LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE IX-A Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE IX-A CAYMAN LIMITED PARTNERSHIP
By: AP GPE IX Limited Partnership, its General Partner
By: Advent International GPE IX, LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE IX-B Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE IX-B CAYMAN LIMITED PARTNERSHIP
By: AP GPE IX Limited Partnership, its General Partner
By: Advent International GPE IX, LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
GPE IX GP Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
GPE IX GP LIMITED PARTNERSHIP
By: Advent International GPE IX, LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
GPE IX GP S.à.r.l.
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
GPE IX GP S.À.R.L.
|
|
|
By: Advent International GPE IX, LLC, its General Partner
|
/s/ Justin Nuccio
|
|
By: Advent International Corporation, its Manager
|
Justin Nuccio, Manager
|
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
AP GPE IX GP Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
AP GPE IX GP LIMITED PARTNERSHIP
By: Advent International GPE IX, LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX, LLC
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE IX, LLC
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT GLOBAL TECHNOLOGY LIMITED PARTNERSHIP
By: Advent Global Technology GP Limited Partnership, its General Partner
By: Advent Global Technology LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology-B Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT GLOBAL TECHNOLOGY-B LIMITED PARTNERSHIP
By: Advent Global Technology GP Limited Partnership, its General Partner
By: Advent Global Technology LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology-C Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT GLOBAL TECHNOLOGY-C LIMITED PARTNERSHIP
By: Advent Global Technology GP Limited Partnership, its General Partner
By: Advent Global Technology LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology-D Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT GLOBAL TECHNOLOGY-D LIMITED PARTNERSHIP
By: Advent Global Technology GP Limited Partnership, its General Partner
By: Advent Global Technology LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology-A SCSP
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT GLOBAL TECHNOLOGY-A SCSP
|
|
|
By: Advent Global Technology GP S.à.r.l., its General Partner
|
|
|
By: Advent Global Technology LLC, its General Partner
|
/s/ Justin Nuccio
|
|
By: Advent International Corporation, its Manager
|
Justin Nuccio, Manager
|
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners AGT Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS AGT LIMITED PARTNERSHIP
By: AP AGT GP Limited Partnership, its General Partner
By: Advent Global Technology LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners AGT-A Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS AGT-A LIMITED PARTNERSHIP
By: AP AGT GP Limited Partnership, its General Partner
By: Advent Global Technology LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners AGT Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS AGT CAYMAN LIMITED PARTNERSHIP
By: AP AGT GP Limited Partnership, its General Partner
By: Advent Global Technology LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology Strategic Investors Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT GLOBAL TECHNOLOGY STRATEGIC INVESTORS LIMITED PARTNERSHIP
By: AP AGT GP Limited Partnership, its General Partner
By: Advent Global Technology LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology GP Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT GLOBAL TECHNOLOGY GP LIMITED PARTNERSHIP
By: Advent Global Technology LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology GP S.à.r.l.
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT GLOBAL TECHNOLOGY GP S.À.R.L.
|
|
|
By: Advent Global Technology LLC, its General Partner
|
/s/ Justin Nuccio
|
|
By: Advent International Corporation, its Manager
|
Justin Nuccio, Manager
|
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
AP AGT GP Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
AP AGT GP LIMITED PARTNERSHIP
By: Advent Global Technology LLC, its General Partner
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology LLC
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT GLOBAL TECHNOLOGY LLC
By: Advent International Corporation, its Manager
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Sunley House Capital Master Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
SUNLEY HOUSE CAPITAL MASTER LIMITED PARTNERSHIP
By: Sunley House Capital GP LP, its General Partner
By: Sunley House Capital GP LLC, its General Partner
By: Advent International Corporation, its Sole Member
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Sunley House Capital GP LP
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
SUNLEY HOUSE CAPITAL GP LP
By: Sunley House Capital GP LLC, its General Partner
By: Advent International Corporation, its Sole Member
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Sunley House Capital GP LLC
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
SUNLEY HOUSE CAPITAL GP LLC
By: Advent International Corporation, its Sole Member
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Sunley House Capital Management LLC
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Earliest Transaction
|
Required to be Reported (Month/Day/Year):
|
November 22, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
SUNLEY HOUSE CAPITAL MANAGEMENT LLC
By: Advent International Corporation, its Sole Member
|
By: /s/ Neil Crawford
|
|
|
Name: Neil Crawford
|
|
|
Title: Director, Fund Administration
|
November 24, 2021
Date